Financhill
Sell
1

CNSWF Quote, Financials, Valuation and Earnings

Last price:
$1,677.25
Seasonality move :
10.68%
Day range:
$1,795.00 - $1,887.47
52-week range:
$1,795.00 - $3,998.72
Dividend yield:
0.22%
P/E ratio:
57.12x
P/S ratio:
3.42x
P/B ratio:
10.98x
Volume:
23.4K
Avg. volume:
12.2K
1-year change:
-45.38%
Market cap:
$38.1B
Revenue:
$10.1B
EPS (TTM):
$31.47
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $4B $5.1B $6.6B $8.4B $10.1B
Revenue Growth (YoY) 13.73% 28.65% 29.69% 26.96% 19.73%
 
Cost of Revenues $2.4B $3.1B $4.2B $5.3B $6.2B
Gross Profit $1.6B $2B $2.5B $3.1B $3.8B
Gross Profit Margin 39.38% 38.62% 37.03% 37.35% 38.01%
 
R&D Expenses $603M $770M $1B $1.3B $1.6B
Selling, General & Admin $38M $54M $86M $111M $130M
Other Inc / (Exp) -$90M -$497M -$217M -$895M -$415M
Operating Expenses $885M $1.1B $1.5B $2B $2.4B
Operating Income $678M $857M $905M $1.2B $1.5B
 
Net Interest Expenses $46M $68M $110M $192M $280M
EBT. Incl. Unusual Items $575M $340M $685M $209M $942M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $139M $173M $135M $152M $175M
Net Income to Company $436M $168M $550M $62M $768M
 
Minority Interest in Earnings -- -$142M $38M -$503M $37M
Net Income to Common Excl Extra Items $436M $168M $550M $62M $767M
 
Basic EPS (Cont. Ops) $20.57 $14.63 $24.16 $26.66 $34.49
Diluted EPS (Cont. Ops) $20.57 $14.63 $24.16 $26.66 $34.49
Weighted Average Basic Share $21.2M $21.2M $21.2M $21.2M $21.2M
Weighted Average Diluted Share $21.2M $21.2M $21.2M $21.2M $21.2M
 
EBITDA $1.2B $1.5B $1.7B $2.2B $2.7B
EBIT $678M $857M $905M $1.2B $1.5B
 
Revenue (Reported) $4B $5.1B $6.6B $8.4B $10.1B
Operating Income (Reported) $678M $857M $905M $1.2B $1.5B
Operating Income (Adjusted) $678M $857M $905M $1.2B $1.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $1.3B $1.7B $2.1B $2.5B $2.9B
Revenue Growth (YoY) 29.51% 32.8% 23.25% 19.52% 16.02%
 
Cost of Revenues $979M $1.3B $1.6B $1.9B $2.2B
Gross Profit $320M $387M $509M $602M $766M
Gross Profit Margin 24.63% 22.44% 23.94% 23.69% 25.98%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $15M $21M $27M $29M $37M
Other Inc / (Exp) -$39M -$50M -$35M -$98M --
Operating Expenses $100M $153M $184M $222M $272M
Operating Income $220M $234M $325M $380M $494M
 
Net Interest Expenses $18M $29M $50M $72M $74M
EBT. Incl. Unusual Items $180M $184M $275M $255M $479M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $60M $41M $56M $68M $57M
Net Income to Company $119.9M $137.2M $218.9M $186.3M $163.7M
 
Minority Interest in Earnings $14M $7M -$8M $23M -$48M
Net Income to Common Excl Extra Items $121M $143M $219M $187M $162M
 
Basic EPS (Cont. Ops) $5.05 $6.42 $10.71 $7.74 $9.91
Diluted EPS (Cont. Ops) $5.05 $6.42 $10.71 $7.74 $9.91
Weighted Average Basic Share $21.2M $21.2M $21.2M $21.2M $21.2M
Weighted Average Diluted Share $21.2M $21.2M $21.2M $21.2M $21.2M
 
EBITDA $385M $449M $580M $697M $853M
EBIT $220M $234M $325M $380M $494M
 
Revenue (Reported) $1.3B $1.7B $2.1B $2.5B $2.9B
Operating Income (Reported) $220M $234M $325M $380M $494M
Operating Income (Adjusted) $220M $234M $325M $380M $494M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $4.8B $6.2B $7.9B $9.7B $11.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.7B $4.7B $6.1B $7.4B $8.3B
Gross Profit $1.2B $1.4B $1.8B $2.3B $2.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $47M $79M $105M $125M $150M
Other Inc / (Exp) -$450M -$209M -$536M -$765M --
Operating Expenses $348M $540M $724M $882M $1.1B
Operating Income $816M $880M $1.1B $1.4B $1.8B
 
Net Interest Expenses $59M $91M $169M $268M $289M
EBT. Incl. Unusual Items $346M $668M $481M $522M $1.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $175M $137M $159M $179M $230M
Net Income to Company $177.2M $524.5M $308.4M $346.2M $732.5M
 
Minority Interest in Earnings -$162M $48M -$253M -$238M $39M
Net Income to Common Excl Extra Items $172M $532M $324M $348M $705M
 
Basic EPS (Cont. Ops) $15.76 $22.84 $27.18 $27.65 $31.47
Diluted EPS (Cont. Ops) $15.76 $22.84 $27.18 $27.65 $31.47
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $1.4B $1.6B $2B $2.6B $3.1B
EBIT $816M $880M $1.1B $1.4B $1.8B
 
Revenue (Reported) $4.8B $6.2B $7.9B $9.7B $11.1B
Operating Income (Reported) $816M $880M $1.1B $1.4B $1.8B
Operating Income (Adjusted) $816M $880M $1.1B $1.4B $1.8B
Period Ending 2022-09-30 2023-09-30 2024-09-30 2025-09-30 2026-09-30
Revenue $4.8B $6.1B $7.4B $8.4B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.7B $4.7B $5.7B $6.3B --
Gross Profit $1.1B $1.3B $1.7B $2.1B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $62M $81M $94M $114M --
Other Inc / (Exp) -$155M -$477M -$345M -$481M --
Operating Expenses $424M $549M $668M $786M --
Operating Income $644M $798M $1B $1.4B --
 
Net Interest Expenses $73M $132M $208M $216M --
EBT. Incl. Unusual Items $498M $294M $607M $861M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $110M $134M $160M $215M --
Net Income to Company $381.3M $162.3M $446.5M $426.4M --
 
Minority Interest in Earnings $28M -$263M $2M $4M --
Net Income to Common Excl Extra Items $388M $162M $447M $386M --
 
Basic EPS (Cont. Ops) $16.99 $20.01 $21.00 $18.03 --
Diluted EPS (Cont. Ops) $16.99 $20.01 $21.00 $18.03 --
Weighted Average Basic Share $63.6M $63.6M $63.6M $63.6M --
Weighted Average Diluted Share $63.6M $63.6M $63.6M $63.6M --
 
EBITDA $1.2B $1.5B $1.9B $2.4B --
EBIT $644M $798M $1B $1.4B --
 
Revenue (Reported) $4.8B $6.1B $7.4B $8.4B --
Operating Income (Reported) $644M $798M $1B $1.4B --
Operating Income (Adjusted) $644M $798M $1B $1.4B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $767M $802M $926M $1.3B $2B
Short Term Investments $9M $39M $115M $14M $14M
Accounts Receivable, Net $581M $740M $1.1B $1.5B $1.7B
Inventory $27M $35M $48M $51M $56M
Prepaid Expenses -- -- -- -- --
Other Current Assets $116M $156M $222M $278M $319M
Total Current Assets $1.6B $1.8B $2.5B $3.3B $4.3B
 
Property Plant And Equipment $337M $338M $411M $454M $551M
Long-Term Investments $2M $2M $3M $10M $14M
Goodwill $431M $610M $792M $1.3B $1.5B
Other Intangibles $1.9B $2.8B $3.9B $5.4B $6B
Other Long-Term Assets $3M -$1M -- $193M $204M
Total Assets $4.4B $5.8B $7.9B $10.9B $12.9B
 
Accounts Payable $666M $832M $1.1B $1.4B $1.6B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $141M $203M $821M $1.1B $622M
Current Portion Of Capital Lease Obligations $74M $79M $96M $112M $115M
Other Current Liabilities $1M $6M -- $814M --
Total Current Liabilities $2B $2.5B $3.8B $5.5B $4.7B
 
Long-Term Debt $623M $1.1B $1.4B $2.5B $3.8B
Capital Leases -- -- -- -- --
Total Liabilities $3.3B $4.2B $5.9B $8.9B $9.6B
 
Common Stock $99M $99M $99M $99M $99M
Other Common Equity Adj -$31M -$66M -$150M -$99M -$224M
Common Equity $1B $1.1B $1.7B $1.9B $2.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $460M $221M $85M $493M
Total Equity $1B $1.5B $1.9B $2B $3.3B
 
Total Liabilities and Equity $4.4B $5.8B $7.9B $10.9B $12.9B
Cash and Short Terms $767M $802M $926M $1.3B $2B
Total Debt $725M $1.4B $2.3B $3.7B $4.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $980M $759M $1.1B $2.1B $3.1B
Short Term Investments $19M $94M $8M $16M --
Accounts Receivable, Net $656M $944M $1.3B $1.6B $1.8B
Inventory $32M $46M $56M $66M $74M
Prepaid Expenses -- -- -- -- --
Other Current Assets $155M $226M $265M $329M --
Total Current Assets $1.9B $2.1B $2.9B $4.4B $5.8B
 
Property Plant And Equipment $343M $385M $411M $543M $619M
Long-Term Investments $2M $2M -- $9M $258M
Goodwill $568M $799M $1.2B $1.4B --
Other Intangibles $2.4B $3.7B $5.2B $5.8B --
Other Long-Term Assets $1M -$1M -- -$1M --
Total Assets $5.4B $7.2B $10B $12.6B $15.3B
 
Accounts Payable $720M $916M $1.2B $1.4B $1.7B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $191M $598M $457M $708M --
Current Portion Of Capital Lease Obligations $81M $89M $103M $113M --
Other Current Liabilities $7M -$1M $535M $1M --
Total Current Liabilities $2.4B $3.3B $5.1B $4.7B $5.7B
 
Long-Term Debt $1.1B $1.4B $2.1B $3.7B $4.2B
Capital Leases -- -- -- -- --
Total Liabilities $4B $5.5B $8B $9.4B $11.2B
 
Common Stock $99M $99M $99M $99M $99M
Other Common Equity Adj -$69M -$227M -$159M -$98M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $429M $196M $304M $478M $634M
Total Equity $1.4B $1.7B $2B $3.1B $4.1B
 
Total Liabilities and Equity $5.4B $7.2B $10B $12.6B $15.3B
Cash and Short Terms $980M $759M $1.1B $2.1B $3.1B
Total Debt $1.3B $2.1B $3.9B $4.5B $5.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $436M $168M $550M $62M $768M
Depreciation & Amoritzation $508M $639M $819M $1B $1.2B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $45M -$35M -$107M -$114M -$67M
Change in Inventories $8M $1M -$9M $4M $6M
Cash From Operations $1.2B $1.3B $1.2B $1.7B $2.1B
 
Capital Expenditures $25M $29M $41M $42M $67M
Cash Acquisitions $477M $1.2B $1.6B $1.6B $1.3B
Cash From Investing -$514M -$1.2B -$1.7B -$1.6B -$1.6B
 
Dividends Paid (Ex Special Dividend) $85M $85M $92M $85M $85M
Special Dividend Paid
Long-Term Debt Issued $48M $176M $798M $656M $1.4B
Long-Term Debt Repaid -$168M -$89M -$196M -$391M -$267M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$2M -$2M -$10M -$3M -$154M
Cash From Financing -$215M -$1M $557M $449M $292M
 
Beginning Cash (CF) $758M $763M $811M $1.3B $2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $442M $5M $47M $473M $695M
Ending Cash (CF) $1.2B $752M $819M $1.8B $2.6B
 
Levered Free Cash Flow $1.1B $1.2B $1.2B $1.6B $2B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $143.2M $146.1M -$100.2M $306.1M --
Depreciation & Amoritzation $171.8M $199.7M $268.6M $298.6M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$48.7M -$80M -$53.7M -$92.5M --
Change in Inventories $2M $2.2M $6M $11.9M --
Cash From Operations $329.7M $340.4M $455.1M $676.4M --
 
Capital Expenditures $10.9M $12.8M $12.5M $23.8M --
Cash Acquisitions $484.9M $169.6M $356.3M $452M --
Cash From Investing -$522.7M -$205.4M -$404M -$553.4M --
 
Dividends Paid (Ex Special Dividend) $20.8M $18.5M $20M $19.5M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $36M $351M $323M -$79M --
Long-Term Debt Repaid -$24M -$97M -$86M -$65M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $3M -$12M -$3M -$3M --
Cash From Financing -$2M -$21.1M $123.6M -$167.2M --
 
Beginning Cash (CF) $763M $811M $1.3B $2B --
Foreign Exchange Rate Adjustment -$3M $28.4M $26.9M -$58M --
Additions / Reductions -$198M $142.4M $201.6M -$102.1M --
Ending Cash (CF) $562M $981.8M $1.5B $1.8B --
 
Levered Free Cash Flow $318.7M $327.6M $442.6M $652.6M --
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $177.2M $524.5M $308.4M $346.2M $732.5M
Depreciation & Amoritzation $606.6M $757.4M $941.2M $1.2B $1.3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$477.9K -$71.3M -$138.4M -$28.1M $8M
Change in Inventories $4.1M -$8.8M $177.3K -$60.7K $10.8M
Cash From Operations $1.3B $1.2B $1.5B $1.8B $2.5B
 
Capital Expenditures $24.1M $37.5M $41.8M $54.4M $71.5M
Cash Acquisitions $920.8M $1.9B $1.4B $1.2B $1.2B
Cash From Investing -$893.6M -$1.9B -$1.4B -$1.4B -$2B
 
Dividends Paid (Ex Special Dividend) $85.3M $90.6M $82.6M $83.9M $84.5M
Special Dividend Paid
Long-Term Debt Issued $166M $483M $684M $1.8B --
Long-Term Debt Repaid -$181M -$123M -$402M -$288M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$7M $5M -- -$154M --
Cash From Financing $8M $553.2M $300.4M $581.8M $89.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $397M -$295.3M $408.1M $994.1M $699.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.3B $1.1B $1.5B $1.7B $2.5B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Net Income to Stockholders $527.4M $62M $752.6M $426.4M --
Depreciation & Amoritzation $785.4M $1B $1.2B $1B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$102.6M -$112.1M -$66.9M $100.5M --
Change in Inventories -$8.6M $4M $5.8M -$1M --
Cash From Operations $1.2B $1.6B $2B $1.9B --
 
Capital Expenditures $39.3M $41.5M $65.7M $47.7M --
Cash Acquisitions $1.6B $1.6B $1.3B $766.5M --
Cash From Investing -$1.6B -$1.6B -$1.6B -$1.4B --
 
Dividends Paid (Ex Special Dividend) $88.2M $84.1M $83.4M $65M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $798M $656M $1.4B $368M --
Long-Term Debt Repaid -$196M -$391M -$267M -$266M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$10M -$3M -$154M -$6M --
Cash From Financing $534.1M $445.1M $291M $256.8M --
 
Beginning Cash (CF) $3.1B $4.3B $8B $8.1B --
Foreign Exchange Rate Adjustment -$37.4M $16.8M -$47.2M $98.5M --
Additions / Reductions $45.1M $467.3M $690.4M $802M --
Ending Cash (CF) $3.2B $4.8B $8.6B $9B --
 
Levered Free Cash Flow $1.1B $1.6B $1.9B $1.8B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 43x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 43x

Alerts

Sell
49
HYMC alert for Feb 3

Hycroft Mining Holding Corp. [HYMC] is up 19.68% over the past day.

Buy
67
FBRX alert for Feb 3

Forte Biosciences, Inc. [FBRX] is down 0.2% over the past day.

Buy
72
BNR alert for Feb 3

Burning Rock Biotech Ltd. [BNR] is down 15.43% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock